Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB treatment news

Show

From To
Patients taking TB treatment may be potentially infectious for longer than previously thought

Patients taking directly observed therapy (DOTS) for tuberculosis (TB) may be potentially infectious for longer than previously thought, investigators report in the August 15th edition of Clinical

Published
10 August 2010
By
Michael Carter
Starting ART two weeks after TB treatment reduces death risk by one-third in people with HIV

Starting antiretroviral therapy (ART) in people with TB and advanced HIV disease two weeks after starting TB therapy, rather than waiting eight weeks, significantly improves survival according to

Published
23 July 2010
By
Theo Smart
Timing of ART initiation during TB treatment may not have significant impact on risk of death

There was no significant difference in the risk of death if antiretroviral (ARV) treatment was initiated within two months of beginning TB treatment or more

Published
15 June 2010
By
Lesley Odendal
HIV & TB in Practice: Improving clinical management of TB in people with HIV

“If HIV and tuberculosis (TB) are both treatable diseases, why do some patients with HIV-associated TB require hospital admission and die?” asked Dr Graeme Meintjes,

Published
11 June 2010
From
HIV & AIDS treatment in practice
WHO issues updated TB treatment guidelines

Treatment regimens for tuberculosis should include an antibiotic of the rifamycin class for the full six months of therapy, according to new World Health Organization

Published
29 April 2010
From
HIV & AIDS treatment in practice
WHO issues updated TB treatment guidelines; experts say lack of trials in TB/HIV patients `striking`

Treatment regimens for tuberculosis should include an antibiotic of the rifamycin class for the full six months of therapy, according to new World Health Organization

Published
15 April 2010
By
Michael Carter
Isoniazid preventive therapy doesn't increase risk of resistant TB

Treatment with isoniazid preventive therapy does not lead to the development of drug-resistant tuberculosis, South African investigators report in the April 24th edition of AIDS.

Published
13 April 2010
By
Michael Carter
HIV and TB in Practice

This articles looks at the issue of isoniazid resistance in isoniazid preventive therapy (IPT) and TB programmes.

Published
21 May 2009
From
HIV & AIDS treatment in practice
Childhood TB (part 3): treatment and prevention

This is the third part of Childhood TB covering treatment and prevention including antiretroviral treatment for children co-infected.

Published
22 December 2008
From
HIV & AIDS treatment in practice
Scaling up laboratory capacity for the coming storm of XDR-TB, and why the HIV treating community must get involved now

Review of issues in monitoring TB drug sensitivity in resource-limited settings, and the need to scale up laboratory capacity in order to detect MDR and

Published
28 November 2006
From
HIV & AIDS treatment in practice

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.